Welcome to the ‘Thrombosis Adviser’ Knowledge Base

This section aims to serve as a comprehensive reference centre, starting with the essentials of understanding thromboembolic diseases, guiding you on to the specific arterial and venous thromboembolic conditions, treatments, prevention and finally special population considerations. The knowledge base allows you to navigate through all of its content quickly and easily.

Venous Thrombosis


An introduction to venous thromboembolic disorders, their incidence and prevalence, and risk factors

Deep Vein Thrombosis

Introduction and Diagnosis

An introduction to DVT and its clinical presentation and diagnosis

Pulmonary Embolism

Introduction and Diagnosis

An introduction to PE and its clinical presentation and diagnosis



VTE is a major healthcare burden

Anticoagulant Therapy

Anticoagulant therapy in patients with VTE

Other Options

Other options for thromboprophylaxis


Treatment of DVT and PE

VTE in Special Populations

Patients with VTE and Renal Impairment

Patients with VTE and renal impairment are at high risk of thrombotic events

Paediatric VTE

VTE is a leading cause of hospital-acquired illness in children

Frail and Elderly Patients with VTE

Elderly patients with frailty are at increased risk of thrombotic events. Treatment outcomes with non-vitamin K antagonist oral anticoagulants (NOACs) from clinical studies are important to consider in this subgroup.

Extended Treatment

The secondary prevention of venous thromboembolism, recurrent VTE and extended anticoagulant treatment


The complications of VTE, including PTS and CTEPH

Cancer-Associated Thrombosis

Introduction to Cancer-Associated Thrombosis

Learn about the epidemiology of cancer-associated thrombosis and its risk factors

Treatment of Cancer-Associated Thrombosis

Find out how different anticoagulant regimens are used for the treatment of cancer-associated thrombosis and prevention of recurrent events